Back

Jamie L. Studts, PhD

Professor, Medicine-Medical Oncology


FacultyPhoto
Graduate Schools
  • MS, University of Kentucky (1992)
  • MA, University of Kentucky (1996)
  • PhD, University of Kentucky (2001)
Undergraduate School
  • BA, Loras College (IA) (1991)
Residency
  • Duke University Hospital Program, Behavioral Medicine (2000)
Languages English
Department Medicine-Medical Oncology

Professional Titles

  • Scientific Director of Behavioral Oncology
  • Co-Leader, Cancer Prevention and Control Program
  • Co-Director, Population Health Shared Resource

Publications

  • Langford AT, Hawley ST, Stableford S, Studts JL, Byrne MM. Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives. J Cancer Educ. 2020 Jun;35(3):454-461. PubMed PMID: 30739270
  • Eberth JM, Ersek JL, Terry LM, Bills SE, Chintanippu N, Carlos R, Hughes DR, Studts JL. Leveraging the Mammography Setting to Raise Awareness and Facilitate Referral to Lung Cancer Screening: A Qualitative Analysis. J Am Coll Radiol. 2020 Jul;17(7):960-969. PubMed PMID: 32112723
  • Byrne MM, Thurer RJ, Studts JL. Individual decision making about lung cancer screening: A conjoint analysis of perspectives among a high-risk national sample. Cancer Med. 2019 Sep;8(12):5779-5786. PubMed PMID: 31385463
  • Knudsen HK, Lofwall MR, Lin LA, Walsh SL, Studts JL. US physicians' decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progress. Drug Alcohol Depend. 2019 Nov 1;204:107490. PubMed PMID: 31518885
  • Byrne MM, Lillie SE, Studts JL. Lung cancer screening in a community setting: Characteristics, motivations, and attitudes of individuals being screened. Health Psychol Open. 2019 Jan-Jun;6(1):2055102918819163. PubMed PMID: 30643640
  • Knudsen HK, Studts JL. Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment. J Behav Health Serv Res. 2019 Jan;46(1):151-163. PubMed PMID: 30069622
  • Price SN, Studts JL, Hamann HA. Tobacco Use Assessment and Treatment in Cancer Patients: A Scoping Review of Oncology Care Clinician Adherence to Clinical Practice Guidelines in the U.S. Oncologist. 2019 Feb;24(2):229-238. PubMed PMID: 30446582
  • Hahn EJ, Huntington-Moskos L, Mundy M, Rademacher K, Wiggins AT, Rayens MK, Studts JL, Butler KM. A Randomized Trial to Test Personalized Environmental Report Back to Reduce Lung Cancer Risk. Health Educ Behav. 2019 Feb;46(1):165-175. PubMed PMID: 30078335
  • Sutton J, Vos SC, Olson MK, Woods C, Cohen E, Gibson CB, Phillips NE, Studts JL, Eberth JM, Butts CT. Lung Cancer Messages on Twitter: Content Analysis and Evaluation. J Am Coll Radiol. 2018 Jan;15(1 Pt B):210-217. PubMed PMID: 29154103
  • Hamann HA, Ver Hoeve ES, Carter-Harris L, Studts JL, Ostroff JS. Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum. J Thorac Oncol. 2018 Aug;13(8):1062-1075. PubMed PMID: 29800746
  • Knudsen HK, Lofwall MR, Walsh SL, Havens JR, Studts JL. Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers. J Addict Med. 2018 Jan Feb;12(1):31-39. PubMed PMID: 28914663
  • Fedewa SA, Kazerooni EA, Studts JL, Smith R, Bandi P, Sauer AG, Cotter M, Sineshaw HM, Jemal A, Silvestri GA. State Variation in Low-Dose CT Scanning for Lung Cancer Screening in the United States. J Natl Cancer Inst. 2020 Nov 12. [Epub ahead of print] PubMed PMID: 33176362
  • Waters EA, Taber JM, McQueen A, Housten AJ, Studts JL, Scherer LD. Translating Cancer Risk Prediction Models into Personalized Cancer Risk Assessment Tools: Stumbling Blocks and Strategies for Success. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2389-2394. PubMed PMID: 33046450
  • Zgodic A, Zahnd WE, Miller DP Jr, Studts JL, Eberth JM. Predictors of Lung Cancer Screening Utilization in a Population-Based Survey. J Am Coll Radiol. 2020 Dec;17(12):1591-1601. PubMed PMID: 32681828
  • Langford A, Studts JL, Byrne MM. Improving knowledge and decision readiness to participate in cancer clinical trials: Effects of a plain language decision aid for minority cancer survivors. Patient Educ Couns. 2020 Jul 7. [Epub ahead of print] PubMed PMID: 32660742
  • Studts JL, Thurer RJ, Brinker K, Lillie SE, Byrne MM. Brief Education and a Conjoint Valuation Survey May Reduce Decisional Conflict Regarding Lung Cancer Screening. MDM Policy Pract. 2020 Jan-Jun;5(1):2381468319891452. PubMed PMID: 31976372
  • Ha DM, Prochazka AV, Bekelman DB, Stevens-Lapsley JE, Studts JL, Keith RL. Modifiable factors associated with health-related quality of life among lung cancer survivors following curative intent therapy. Lung Cancer. 2022 Jan;163:42-50. PubMed PMID: 34896804
  • Burris JL, Borger TN, Shelton BJ, Darville AK, Studts JL, Valentino J, Blair C, Davis DB, Scales J. Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute-Designated Cancer Center. JCO Oncol Pract. 2021 Jun 29;:OP2001095. [Epub ahead of print] PubMed PMID: 34185570
  • Bastos de Carvalho A, Lee Ware S, Belcher T, Mehmeti F, Higgins EB, Sprang R, Williams C, Studts JL, Studts CR. Evaluation of multi-level barriers and facilitators in a large diabetic retinopathy screening program in federally qualified health centers: a qualitative study. Implement Sci Commun. 2021 May 22;2(1):54. PubMed PMID: 34022946
  • Hirsch EA, Barón AE, Risendal B, Studts JL, New ML, Malkoski SP. Determinants Associated With Longitudinal Adherence to Annual Lung Cancer Screening: A Retrospective Analysis of Claims Data. J Am Coll Radiol. 2021 Aug;18(8):1084-1094. PubMed PMID: 33798496
  • Hamann HA, Williamson TJ, Studts JL, Ostroff JS. Lung Cancer Stigma Then and Now: Continued Challenges Amid a Landscape of Progress. J Thorac Oncol. 2021 Jan;16(1):17-20. PubMed PMID: 33384057
  • Langford A, Studts JL, Byrne MM. Improving knowledge and decision readiness to participate in cancer clinical trials: Effects of a plain language decision aid for minority cancer survivors. Patient Educ Couns. 2021 Feb;104(2):422-426. PubMed PMID: 32660742
  • Williams LB, Shelton BJ, Gomez ML, Al-Mrayat YD, Studts JL. Using Implementation Science to Disseminate a Lung Cancer Screening Education Intervention Through Community Health Workers. J Community Health. 2021 Feb;46(1):165-173. PubMed PMID: 32594413
  • Hirsch EA, Barón AE, Risendal B, Studts JL, New ML, Malkoski SP. Authors' Response. J Am Coll Radiol. 2022 Mar;19(3):404-405. PubMed PMID: 35143785
  • Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes M. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw. 2022 Jul;20(7):754-764. PubMed PMID: 35830884
  • Brtnikova M, Studts JL, Robertson E, Dickinson LM, Carroll JK, Krist AH, Cronin JT, Glasgow RE. Priorities for improvement across cancer and non-cancer related preventive services among rural and non-rural clinicians. BMC Prim Care. 2022 Sep 9;23(1):231. PubMed PMID: 36085005
  • Studts JL, Hirsch EA, Silvestri GA. Shared Decision-Making During a Lung Cancer Screening Visit: Is It a Barrier or Does It Bring Value?. Chest. 2023 Jan;163(1):251-254. PubMed PMID: 35940213
  • Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes M. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw. 2022 Jul;20(7):754-764. PubMed PMID: 35830884
  • Borger T, Shelton BJ, Valentino J, Ostroff JS, Cummings KM, Studts JL, Carpenter MJ, Burris JL. A Daily Assessment Study of Smoking Cessation After a Head and Neck Cancer Diagnosis. Nicotine Tob Res. 2022 Oct 26;24(11):1781-1788. PubMed PMID: 35486923
  • Ware SL, Studts CR, Lei F, Bush H, Higgins EB, Studts JL, Bastos de Carvalho A. Ranked determinants of telemedicine diabetic retinopathy screening performance in the United States primary care safety-net setting: an exploratory CART analysis. BMC Health Serv Res. 2022 Apr 14;22(1):507. PubMed PMID: 35421978
  • Hirsch EA, Barón AE, Risendal B, Studts JL, New ML, Malkoski SP. Authors' Response. J Am Coll Radiol. 2022 Mar;19(3):404-405. PubMed PMID: 35143785
  • Ha DM, Prochazka AV, Bekelman DB, Stevens-Lapsley JE, Studts JL, Keith RL. Modifiable factors associated with health-related quality of life among lung cancer survivors following curative intent therapy. Lung Cancer. 2022 Jan;163:42-50. PubMed PMID: 34896804
  • Burris JL, Borger TN, Shelton BJ, Darville AK, Studts JL, Valentino J, Blair C, Davis DB, Scales J. Tobacco Use and Tobacco Treatment Referral Response of Patients With Cancer: Implementation Outcomes at a National Cancer Institute-Designated Cancer Center. JCO Oncol Pract. 2022 Feb;18(2):e261-e270. PubMed PMID: 34185570
  • Banerjee SC, Malling CD, Shen MJ, Williamson TJ, Bylund CL, Studts JL, Mullett T, Carter-Bawa L, Hamann HA, Parker PA, Steliga M, Feldman J, Pantelas J, Borondy-Kitts A, Rigney M, King JC, Fathi JT, Rosenthal LS, Smith RA, Ostroff JS. Getting ready for prime time: Recommended adaptations of an Empathic Communication Skills training intervention to reduce lung cancer stigma for a national multi-center trial. Transl Behav Med. 2023 Sep 28;13(10):804-808. PubMed PMID: 37579304
  • Glasgow RE, Brtnikova M, Dickinson LM, Carroll JK, Studts JL. Implementation strategies preferred by primary care clinicians to facilitate cancer prevention and control activities. J Behav Med. 2023 Oct;46(5):821-836. PubMed PMID: 37031347
  • Studts JL, Hamann HA. Implementing Evidence-Based Tobacco Treatment Interventions in Oncology to Achieve Optimal Outcomes. J Clin Oncol. 2023 May 20;41(15):2698-2700. PubMed PMID: 36926991
  • Shields PG, Bierut L, Arenberg D, Balis D, Cinciripini PM, Davis J, Edmondson D, Feliciano J, Hitsman B, Hudmon KS, Jaklitsch MT, Leone FT, Ling P, McCarthy DE, Ong MK, Park ER, Prochaska J, Sandoval AJ, Sheffer CE, Spencer S, Studts JL, Tanvetyanon T, Tindle HA, Tong E, Triplette M, Urbanic J, Videtic G, Warner D, Whitlock CW, McCullough B, Darlow S. Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 Mar;21(3):297-322. PubMed PMID: 36898367
  • Kelly KM, Rai P, Studts JL, Dickinson S, Henschel B, Dignan M, Chambers M, Hazard-Jenkins H. Communication with physicians and family about breast Cancer recurrence. PEC Innov. 2023 Dec 15;3:100237. PubMed PMID: 38148854
  • Carter-Bawa L, Ostroff JS, Hoover K, Studts JL. Effective Communication About Lung Cancer Screening Without Iatrogenic Stigma: A Brief Report Case Study Using the Lung Cancer Stigma Communications Assessment Tool of LungTalk. JTO Clin Res Rep. 2023 Nov;4(11):100585. PubMed PMID: 38029025
  • Bilenduke E, Anderson S, Brenner A, Currier J, Eberth JM, King J, Land SR, Risendal BC, Shannon J, Siegel LN, Wangen M, Waters AR, Zahnd WE, Studts JL. Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobacco. Cancer Causes Control. 2023 Dec;34(Suppl 1):209-216. PubMed PMID: 37713024
  • Banerjee SC, Malling CD, Shen MJ, Williamson TJ, Bylund CL, Studts JL, Mullett T, Carter-Bawa L, Hamann HA, Parker PA, Steliga M, Feldman J, Pantelas J, Borondy-Kitts A, Rigney M, King JC, Fathi JT, Rosenthal LS, Smith RA, Ostroff JS. Getting ready for prime time: Recommended adaptations of an Empathic Communication Skills training intervention to reduce lung cancer stigma for a national multi-center trial. Transl Behav Med. 2023 Sep 28;13(10):804-808. PubMed PMID: 37579304
  • Ha DM, Nunnery MA, Klocko RP, Haverhals LM, Bekelman DB, New ML, Randhawa SK, Stevens-Lapsley JE, Studts JL, Prochazka AV, Keith RL. Lung cancer survivors' views on telerehabilitation following curative intent therapy: a formative qualitative study. BMJ Open. 2023 Jun 23;13(6):e073251. PubMed PMID: 37355268
  • Hirsch EA, Studts JL. Using User-Centered Design to Facilitate Adherence to Annual Lung Cancer Screening: Protocol for a Mixed Methods Study for Intervention Development. JMIR Res Protoc. 2023 Apr 14;12:e46657. PubMed PMID: 37058339
  • Glasgow RE, Brtnikova M, Dickinson LM, Carroll JK, Studts JL. Implementation strategies preferred by primary care clinicians to facilitate cancer prevention and control activities. J Behav Med. 2023 Oct;46(5):821-836. PubMed PMID: 37031347
  • Studts JL, Hamann HA. Implementing Evidence-Based Tobacco Treatment Interventions in Oncology to Achieve Optimal Outcomes. J Clin Oncol. 2023 May 20;41(15):2698-2700. PubMed PMID: 36926991
  • Shields PG, Bierut L, Arenberg D, Balis D, Cinciripini PM, Davis J, Edmondson D, Feliciano J, Hitsman B, Hudmon KS, Jaklitsch MT, Leone FT, Ling P, McCarthy DE, Ong MK, Park ER, Prochaska J, Sandoval AJ, Sheffer CE, Spencer S, Studts JL, Tanvetyanon T, Tindle HA, Tong E, Triplette M, Urbanic J, Videtic G, Warner D, Whitlock CW, McCullough B, Darlow S. Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 Mar;21(3):297-322. PubMed PMID: 36898367
  • Gomes R, Nederveld A, Glasgow RE, Studts JL, Holtrop JS. Lung cancer screening in rural primary care practices in Colorado: time for a more team-based approach?. BMC Prim Care. 2023 Mar 3;24(1):62. PubMed PMID: 36869308
  • Studts JL, Hirsch EA, Silvestri GA. Shared Decision-Making During a Lung Cancer Screening Visit: Is It a Barrier or Does It Bring Value?. Chest. 2023 Jan;163(1):251-254. PubMed PMID: 35940213
  • McLouth LE, Borger T, Bursac V, Hoerger M, McFarlin J, Shelton S, Shelton B, Shearer A, Kiviniemi MT, Stapleton JL, Mullett T, Studts JL, Goebel D, Thind R, Trice L, Schoenberg NE. Palliative care use and utilization determinants among patients treated for advanced stage lung cancer care in the community and academic medical setting. Support Care Cancer. 2023 Feb 27;31(3):190. PubMed PMID: 36847880
View All (49 Total) View Less

Professional Memberships

  • Society of Behavioral Medicine, Fellow
  • American Society for Preventive Oncology, Member
  • American Psychosocial Oncology Society, Member
  • Society for Medical Decision Making, Member
  • International Association for the Study of Lung Cancer, Member
  • American Psychological Association, Member
  • American Psychosomatic Society, Member

Specialty Information

Specialties
  • Psychology
Conditions & Treatments
  • Cancers - Lung Cancer
  • Cancers
  • Cancers - Head and Neck Cancer
  • Cancers - Living with Cancer
  • Cancers - Cancer Prevention
Public Speaking
Yes
Lung Cancer Screening Lung Cancer Survivorship Lung Cancer Stigma Tobacco Treatment Team Science

General Information

Graduate Schools
  • MS, University of Kentucky (1992)
  • MA, University of Kentucky (1996)
  • PhD, University of Kentucky (2001)
Undergraduate Schools
  • BA, Loras College (IA) (1991)
Residency Programs
  • Duke University Hospital Program, Behavioral Medicine(2000)
Languages English
Department Medicine-Medical Oncology